drugset / Trial / NCT07533292

Bacteriophage Therapy for Orthopedic Implant-Associated Infections

NCT07533292 ↗

NaSingle-groupOpen-labelTreatment

Summary

A Prospective, Single-Center, Single-Arm Clinical Study with a Pre-Post Self-Controlled Design Evaluating the Efficacy and Safety of Bacteriophage Therapy for Refractory Orthopedic Implant-Associated Infections

Timeline

Start
2026-04-05
Primary completion
2029-12-31
Completion
2030-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject bacteriophage preparation Other / unclassified — Other